Cargando…
Disruptive Technology: CRISPR/Cas-Based Tools and Approaches
Designer nucleases are versatile tools for genome modification and therapy development and have gained widespread accessibility with the advent of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein (Cas) technology. Prokaryotic RNA-guided nucleases of CRISPR...
Autores principales: | Patsali, Petros, Kleanthous, Marina, Lederer, Carsten W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469582/ https://www.ncbi.nlm.nih.gov/pubmed/30945167 http://dx.doi.org/10.1007/s40291-019-00391-4 |
Ejemplares similares
-
Rare Opportunities: CRISPR/Cas-Based Therapy Development for Rare Genetic Diseases
por: Papasavva, Panayiota, et al.
Publicado: (2019) -
CRISPR Editing Enables Consequential Tag-Activated MicroRNA-Mediated Endogene Deactivation
por: Papasavva, Panayiota L., et al.
Publicado: (2022) -
The Scope for Thalassemia Gene Therapy by Disruption of Aberrant Regulatory Elements
por: Patsali, Petros, et al.
Publicado: (2019) -
Relative and Absolute Quantification of Aberrant and Normal Splice Variants in HBB(IVSI−110 (G > A)) β-Thalassemia
por: Patsali, Petros, et al.
Publicado: (2020) -
Distinct miRNA Signatures and Networks Discern Fetal from Adult Erythroid Differentiation and Primary from Immortalized Erythroid Cells
por: Papasavva, Panayiota L., et al.
Publicado: (2021)